Associations between circulating components of the renin-angiotensin-aldosterone system and left ventricular mass.

H. Schunkert, H. W. Hense, M. Muscholl, A. Luchner, S. Kürzinger, A. H. Danser, G. A. Riegger

Klinik und Poliklinik für Innere Medizin II, University of Regensburg, Germany.

OBJECTIVE: Cardiac growth may be modulated in part by the trophic effects of neurohormones. The aim of the present study was to investigate the relation between the basal activity of the renin-angiotensin-aldosterone system and left ventricular mass. DESIGN: A population based sample of 615 middle-age subjects was studied by standardised echocardiography; anthropometric measurements; and biochemical quantification of renin, pro-renin, angiotensinogen, angiotensin converting enzyme (ACE), and aldosterone. RESULTS: Echocardiographic left ventricular mass index correlated significantly with arterial blood pressure, age, and body mass index. In addition, in men ACE activity was significantly related to left ventricular mass index in univariate (P = 0.0007) and multivariate analyses (P = 0.008). Men with left ventricular hypertrophy presented with significantly higher serum ACE concentrations than those with normal left ventricular mass index (P = 0.002). In both men and women serum aldosterone was strongly related to septal and posterior wall thickness. Furthermore, in women serum aldosterone was positively and independently associated with left ventricular mass index (P = 0.0001). This effect was most prominent in hypertensive women. Finally, women with left ventricular hypertrophy presented with significantly higher serum aldosterone (P = 0.01). No significant associations with left ventricular mass index were observed for angiotensinogen, renin, or pro-renin. CONCLUSIONS: The data suggest that the variability of serum ACE or aldosterone, as occurred in this large population based sample, may contribute to the modulation of left ventricular mass.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Jin, Y., Kuznetsova, T., Maillard, M., Richart, T., Thijs, L., Bochud, M., Herregods, M.-C., Burnier, M., Fagard, R., Staessen, J. A. (2009). Independent Relations of Left Ventricular Structure With the 24-Hour Urinary Excretion of Sodium and Aldosterone. Hypertension 54: 489-495 [Abstract] [Full Text]  
• Xue, B., Badaue-Passos, D. Jr, Guo, F., Gomez-Sanchez, C. E., Hay, M., Johnson, A. K. (2009). Sex differences and central protective effect of 17{beta}-estradiol in the development of aldosterone/NaCl-induced hypertension. Am. J. Physiol. Heart Circ. Physiol. 296: H1577-H1585 [Abstract] [Full Text]  
• Velagaleti, R. S., Gona, P., Levy, D., Aragam, J., Larson, M. G., Tofler, G. H., Lieb, W., Wang, T. J., Benjamin, E. J., Vasan, R. S. (2008). Relations of Biomarkers Representing Distinct Biological Pathways to Left Ventricular Geometry. Circulation 118: 2252-2258 [Abstract] [Full Text]  
• Muto, T., Ueda, N., Opthof, T., Ohkusa, T., Nagata, K., Suzuki, S., Tsuji, Y., Horiba, M., Lee, J.-K., Honjo, H., Kamiya, K., Kodama, I., Yasui, K. (2007). Aldosterone modulates If current through gene expression in cultured neonatal rat ventricular myocytes. Am. J. Physiol. Heart Circ. Physiol. 293: H2710-H2718 [Abstract] [Full Text]  
• Arias-Loza, P.-A., Hu, K., Dienesch, C., Mehlich, A. M., Konig, S., Jazbutyte, V., Neyses, L., Hegele-Hartung, C., Heinrich Fritzemeier, K., Pelzer, T. (2007). Both Estrogen Receptor Subtypes, {alpha} and {beta}, Attenuate Cardiovascular Remodeling in Aldosterone Salt-Treated Rats. Hypertension 50: 432-438 [Abstract] [Full Text]  
• Lieb, W., Mayer, B., Schunkert, H. (2007). Reply. Nephrol Dial Transplant 22: 1788-1788 [Full Text]  
• Kuch, B., von Scheidt, W., Peter, W., Doring, A., Piehlmeier, W., Landgraf, R., Meisinger, C. (2007). Sex-Specific Determinants of Left Ventricular Mass in Pre-Diabetic and Type 2 Diabetic Subjects: The Augsburg Diabetes Family Study. Diabetes Care 30: 946-952 [Abstract] [Full Text]  
• Wenxia Chai, , Hoedemaekers, Y. M, van Schaik, R. H., van Fessem, M., Garrelds, I. M, Saris, J. J, Dooijes, D., ten Cate, F. J, Kofflard, M. M., Danser, A. J. (2006). Cardiac aldosterone in subjects with hypertrophic cardiomyopathy. Journal of Renin-Angiotensin-Aldosterone System 7: 225-230 [Abstract]  
• Anand, K., Mooss, A. N, Mohiuddin, S. M (2006). Review: Aldosterone Inhibition Reduces the Risk of Sudden Cardiac Death in Patients with Heart Failure. Journal of Renin-Angiotensin-Aldosterone System 7: 15-19 [Abstract]  
• Ye, P., Kenyon, C. J., MacKenzie, S. M., Jong, A. S., Miller, C., Gray, G. A., Wallace, A., Ryding, A. S., Mullins, J. J., McBride, M. W., Graham, D., Fraser, R., Connell, J. M. C., Davies, E. (2005). The Aldosterone Synthase (CYP11B2) and 11{beta}-Hydroxylase (CYP11B1) Genes Are Not Expressed in the Rat Heart. Endocrinology 146: 5287-5293 [Abstract] [Full Text]  
• Glorioso, N., Filigheddu, F., Parpaglia, P. P., Soro, A., Troffa, C., Argiolas, G., Mulatero, P. (2005). 11{beta}-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension. Eur Heart J 26: 498-504 [Abstract] [Full Text]  
• Gomez-Sanchez, E. P., Ahmad, N., Romero, D. G., Gomez-Sanchez, C. E. (2004). Origin of Aldosterone in the Rat Heart. Endocrinology 145: 4796-4802 [Abstract] [Full Text]  
• Vasan, R. S., Evans, J. C., Larson, M. G., Wilson, P. W.F., Meigs, J. B., Rifai, N., Benjamin, E. J., Levy, D. (2004). Serum Aldosterone and the Incidence of Hypertension in Nonhypertensive Persons. NEJM 351: 33-41 [Abstract] [Full Text]  
• Vasan, R. S., Evans, J. C., Benjamin, E. J., Levy, D., Larson, M. G., Sundstrom, J., Murabito, J. M., Sam, F., Colucci, W. S., Wilson, P. W. F. (2004). Relations of Serum Aldosterone to Cardiac Structure: Gender-Related Differences in the Framingham Heart Study. Hypertension 43: 957-962 [Abstract] [Full Text]  
• Duprez, D. A. (2004). Is the Female Heart More Sensitive to Aldosterone for Early Remodeling?. Hypertension 43: 936-937 [Full Text]  
• Cohn, J. N., Anand, I. S., Latini, R., Masson, S., Chiang, Y.-T., Glazer, R. (2003). Sustained Reduction of Aldosterone in Response to the Angiotensin Receptor Blocker Valsartan in Patients With Chronic Heart Failure: Results From the Valsartan Heart Failure Trial. Circulation 108: 1306-1309 [Abstract] [Full Text]  
• Montgomery, H., Humphries, S., Danilov, S. (2002). Is genotype or phenotype the better tool for investigating the role of ACE in human cardiovascular disease?. Eur Heart J 23: 1083-1086 [Full Text]  
• Fischer, M., Baessler, A., Schunkert, H. (2002). Renin angiotensin system and gender differences in the cardiovascular system. Cardiovasc Res 53: 672-677 [Abstract] [Full Text]  
• Ferrari, R., Guardigli, G., Cicchitelli, G., Valgimigli, M., Merli, E., Soukhomorskaia, O., Ceconi, C. (2002). Angiotensin II overproduction: enemy of the vessel wall. Eur Heart J Suppl 4: A26-A30 [Abstract]  
• Hayashi, M., Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Tsutsui, T., Matsui, T., Fujii, M., Matsumoto, T., Yamamoto, T., Horie, H., Ohnishi, M., Kinoshita, M. (2001). Relationship between transcardiac extraction of aldosterone and left ventricular remodeling in patients with first acute myocardial infarction: extracting aldosterone through the heart promotes ventricular remodeling after acute myocardial infarction. J Am Coll Cardiol 38: 1375-1382 [Abstract] [Full Text]  
• Gomez-Sanchez, C. E., Gomez-Sanchez, E. P. (2001). Cardiac Steroidogenesis--New Sites of Synthesis, or Much Ado About Nothing?. J. Clin. Endocrinol. Metab. 86: 5118-5120 [Full Text]  
• Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., Matsui, T., Kinoshita, M. (2001). Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. J Am Coll Cardiol 37: 1228-1233 [Abstract] [Full Text]  
• Delles, C., Erdmann, J., Jacobi, J., Hilgers, K. F., Fleck, E., Regitz-Zagrosek, V., Schmieder, R. E. (2001). Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension. J Am Coll Cardiol 37: 878-884 [Abstract] [Full Text]  
• Tsutamoto, T., Wada, A., Maeda, K., Mabuchi, N., Hayashi, M., Tsutsui, T., Ohnishi, M., Sawaki, M., Fujii, M., Matsumoto, T., Horie, H., Sugimoto, Y., Kinoshita, M. (2000). Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 36: 838-844 [Abstract] [Full Text]  
• Hengstenberg, C., Holmer, S. R., Mayer, B., Lowel, H., Engel, S., Hense, H.-W., Riegger, G. A. J., Schunkert, H. (2000). Evaluation of the Aldosterone Synthase (CYP11B2) Gene Polymorphism in Patients With Myocardial Infarction. Hypertension 35: 704-709 [Abstract] [Full Text]  
• Schunkert, H., Hengstenberg, C., Holmer, S. R., Broeckel, U., Luchner, A., Muscholl, M. W., Kurzinger, S., Doring, A., Hense, H.-W., Riegger, G. A. J. (1999). Lack of Association Between a Polymorphism of the Aldosterone Synthase Gene and Left Ventricular Structure. Circulation 99: 2255-2260 [Abstract] [Full Text]  
• Schunkert, H., Brockel, U., Hengstenberg, C., Luchner, A., Muscholl, M. W., Kurzidim, K., Kuch, B., Doring, A., Riegger, G.u. A. J., Hense, H.-W. (1999). Familial predisposition of left ventricular hypertrophy. J Am Coll Cardiol 33: 1685-1691 [Abstract] [Full Text]  
• Thurmann, P. A., Kenedi, P., Schmidt, A., Harder, S., Rietbrock, N. (1998). Influence of the Angiotensin II Antagonist Valsartan on Left Ventricular Hypertrophy in Patients With Essential Hypertension. Circulation 98: 2037-2042 [Abstract] [Full Text]  
• Holmer, S R, Hense, H-W, Danser, A H J, Mayer, B, Riegger, G A J, Schunkert, H (1998). beta Adrenergic blockers lower renin in patients treated with ACE inhibitors and diuretics. Heart 80: 45-48 [Abstract] [Full Text]